Acumen Pharmaceuticals Inc (ABOS) Annual Balance Sheets

Annual · GAAP · USD millions
Access ABOS quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Acumen Pharmaceuticals Inc's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent53.99
Marketable Securities, Current SH62.88
Cash & Short-term Investments115.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current5.39
Total Current Assets122.25
Equipment/Property/Plant Net0.00
Long-term investments0.00
Other Assets, Noncurrent0.58
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Operating Lease Right Of Use Asset-
Total Assets122.83
Liabilities
Accounts Payable, Current AC0.55
Accrued Liabilities, Current AC10.07
Short-term Debt DE18.77
Other Liabilities, Current0.00
Total Current Liabilities30.01
Long-term debt22.40
Total Long-term Debt22.40
Combined Long+Short Total Debt (filer-reported)31.16
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent-
Accrued Clinical Trial Expenses Current10.62
Total Liabilities52.40
Stockholders' Equity
Aoci Before Tax Attributable To Parent-
Common Stock Value0.01
Additional Paid In Capital Common Stock516.80
Retained Earnings / Accumulated Deficit-446.46
Other Equity0.08
Common Stockholder's Equity70.43
Total Stockholder's Equity70.43
Liabilities & Stockholder's Equity122.83
4 historic quarters locked

Sign in to unlock the full Acumen Pharmaceuticals Inc balance sheet history.

About Acumen Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-021413

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.